Helena Johansson

Q: What Schools Are Affiliated With Helena Johansson

Helena Johansson is affiliated with the following schools: University of Sheffield, Australian Catholic University, University of Gothenburg

Helena Johansson's AcademicInfluence.com Rankings

Helena Johansson

Philosophy

#9074

World Rank

#12576

Historical Rank

Logic

#6070

World Rank

#7551

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Helena Johansson's Degrees

Masters Biotechnology University of Gothenburg

Why Is Helena Johansson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Helena Johansson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

FRAX™ and the assessment of fracture probability in men and women from the UK (2008) (2130)
Predictive Value of BMD for Hip and Other Fractures (2005) (1308)
A meta-analysis of previous fracture and subsequent fracture risk. (2004) (1162)
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women (2007) (1115)
A systematic review of hip fracture incidence and probability of fracture worldwide (2012) (1074)
A reference standard for the description of osteoporosis. (2008) (941)
Smoking and fracture risk: a meta-analysis (2005) (878)
Assessment of fracture risk (2005) (771)
A Meta‐Analysis of Prior Corticosteroid Use and Fracture Risk (2004) (760)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008) (760)
FRAX and its applications to clinical practice. (2009) (657)
Alcohol intake as a risk factor for fracture (2005) (599)
Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK (2008) (578)
A Meta‐Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX (2016) (467)
Interpretation and use of FRAX in clinical practice (2011) (465)
Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. (1999) (465)
A family history of fracture and fracture risk: a meta-analysis. (2004) (409)
A Meta‐Analysis of the Association of Fracture Risk and Body Mass Index in Women (2014) (397)
Development and use of FRAX® in osteoporosis (2010) (352)
Burden of high fracture probability worldwide: secular increases 2010–2040 (2015) (321)
FRAX underestimates fracture risk in patients with diabetes (2012) (317)
A systematic review of intervention thresholds based on FRAX (2016) (299)
Independent clinical validation of a Canadian FRAX tool: Fracture prediction and model calibration (2010) (249)
Guidance for the adjustment of FRAX according to the dose of glucocorticoids (2011) (246)
Imminent risk of fracture after fracture (2017) (236)
Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures (2008) (219)
Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women (2009) (193)
Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™) (2008) (187)
Caries Development from 11 to 22 Years of Age: A Prospective Radiographic StudyPrevalence and Distribution (1997) (181)
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos (2011) (171)
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX. (2009) (171)
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures (2019) (168)
FRAX® with and without Bone Mineral Density (2011) (166)
Cortical Porosity Identifies Women With Osteopenia at Increased Risk for Forearm Fractures (2014) (162)
Adjusting Fracture Probability by Trabecular Bone Score (2015) (148)
Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study (2012) (145)
Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study (2009) (144)
A Meta-Analysis of Reference Markers of Bone Turnover for Prediction of Fracture (2014) (144)
A meta-analysis of milk intake and fracture risk: low utility for case finding (2005) (143)
Optimization of BMD Measurements to Identify High Risk Groups for Treatment—A Test Analysis (2004) (141)
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment (2011) (134)
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX (2012) (131)
Spine–hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement (2011) (130)
BMD, clinical risk factors and their combination for hip fracture prevention (2009) (127)
A brief history of FRAX (2018) (126)
SCOPE 2021: a new scorecard for osteoporosis in Europe (2021) (124)
The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach (2005) (121)
FRAX® assessment of osteoporotic fracture probability in Switzerland (2010) (118)
Does osteoporosis therapy invalidate FRAX for fracture prediction? (2012) (112)
The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. (1999) (110)
The burden of hospitalised fractures in Sweden (2005) (109)
The use of multiple sites for the diagnosis of osteoporosis (2006) (109)
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden (2004) (108)
Fracture risk assessment without bone density measurement in routine clinical practice (2011) (107)
Lumbar spine texture enhances 10-year fracture probability assessment (2014) (104)
Intervention Thresholds and the Diagnosis of Osteoporosis (2015) (101)
Assessing the Impact of Osteoporosis on the Burden of Hip Fractures (2012) (101)
A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX. (2010) (100)
The potential impact of new National Osteoporosis Foundation guidance on treatment patterns (2009) (99)
Worldwide uptake of FRAX (2014) (99)
Pitfalls in the external validation of FRAX (2012) (98)
High fracture probability with FRAX® usually indicates densitometric osteoporosis: implications for clinical practice (2011) (97)
The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008 (2012) (96)
Characteristics of recurrent fractures (2018) (96)
The effects of a FRAX® revision for the USA (2009) (94)
Longer Duration of Diabetes Strongly Impacts Fracture Risk Assessment: The Manitoba BMD Cohort (2016) (86)
Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study (2009) (85)
Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry (2018) (84)
A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX® (2011) (81)
A FRAX® model for the assessment of fracture probability in Belgium (2009) (80)
From relative risk to absolute fracture risk calculation: The FRAX algorithm (2009) (78)
Epidemiology of fracture in the Russian Federation and the development of a FRAX model (2012) (77)
A decade of FRAX: how has it changed the management of osteoporosis? (2020) (72)
Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis (2015) (71)
Estimated Lean Mass and Fat Mass Differentially Affect Femoral Bone Density and Strength Index but Are Not FRAX Independent Risk Factors for Fracture (2014) (71)
Assessment of the 10‐Year Probability of Osteoporotic Hip Fracture Combining Clinical Risk Factors and Heel Bone Ultrasound: The EPISEM Prospective Cohort of 12,958 Elderly Women (2008) (68)
FRAX Update. (2017) (67)
Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland (2012) (67)
Smoking predicts incident fractures in elderly men: Mr OS Sweden (2009) (65)
Incidence of hip fracture in Brazil and the development of a FRAX model (2015) (65)
Increasing age- and sex-specific rates of hip fracture in Mexico: a survey of the Mexican institute of social security (2011) (65)
Measures of Physical Performance and Muscle Strength as Predictors of Fracture Risk Independent of FRAX, Falls, and aBMD: A Meta‐Analysis of the Osteoporotic Fractures in Men (MrOS) Study (2018) (65)
Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden (2012) (62)
The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population. (2003) (62)
FRAX and fracture prediction without bone mineral density (2015) (62)
Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures (2013) (60)
Falls Predict Fractures Independently of FRAX Probability: A Meta‐Analysis of the Osteoporotic Fractures in Men (MrOS) Study (2017) (59)
The incidence and risk of hip fracture in Poland (2009) (58)
Overview of Fracture Prediction Tools. (2017) (56)
Fall Risk Assessment Predicts Fall‐Related Injury, Hip Fracture, and Head Injury in Older Adults (2016) (55)
FRAX-based assessment and intervention thresholds—an exploration of thresholds in women aged 50 years and older in the UK (2015) (54)
The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX® (2010) (54)
Association of Mental Disorders and Related Medication Use With Risk for Major Osteoporotic Fractures (2017) (52)
Approaches to the targeting of treatment for osteoporosis (2009) (51)
Hip axis length is a FRAX- and bone density-independent risk factor for hip fracture in women. (2015) (51)
High serum adiponectin predicts incident fractures in elderly men: Osteoporotic fractures in men (MrOS) Sweden (2012) (51)
Fracture risk assessment. (2012) (50)
Impact of Femoral Neck and Lumbar Spine BMD Discordances on FRAX Probabilities in Women: A Meta-analysis of International Cohorts (2014) (48)
Adjusting Hip Fracture Probability in Men and Women Using Hip Axis Length: the Manitoba Bone Density Database. (2016) (46)
Cortical Bone Area Predicts Incident Fractures Independently of Areal Bone Mineral Density in Older Men (2016) (46)
The Effect of Abaloparatide‐SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study (2017) (46)
A comparison of case-finding strategies in the UK for the management of hip fractures (2012) (46)
Clinical Utility of Using Lumbar Spine Trabecular Bone Score to Adjust Fracture Probability: The Manitoba BMD Cohort (2017) (46)
FRAX-based intervention and assessment thresholds in seven Latin American countries (2018) (46)
Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures—A Post Hoc Analysis of the SCOOP Study (2018) (46)
Assessment of fracture risk. (2009) (45)
Ten-year fracture probability in Hong Kong Southern Chinese according to age and BMD femoral neck T-scores (2009) (44)
Fracture risk following high-trauma versus low-trauma fracture: a registry-based cohort study (2020) (42)
The Effect of Latitude on the Risk and Seasonal Variation in Hip Fracture in Sweden (2014) (42)
FRAX predicts incident falls in elderly men: findings from MrOs Sweden (2015) (41)
FRAX and the effect of teriparatide on vertebral and non-vertebral fracture (2015) (41)
Adjusting conventional FRAX estimates of fracture probability according to the recency of sentinel fractures (2020) (41)
FRAX and its applications in health economics--cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example. (2010) (40)
Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures (2011) (40)
Performance of FRAX in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry‐Based Cohort Study (2019) (39)
Incidence of Hip Fracture in Romania and the Development of a Romanian FRAX Model (2013) (39)
Can fall risk be incorporated into fracture risk assessment algorithms: a pilot study of responsiveness to clodronate (2009) (39)
FRAX- vs. T-score-based intervention thresholds for osteoporosis (2017) (38)
Predictive value of BMD for hip and other fractures (Journal of Bone and Mineral Research (2005) 20, (1185-1194)) (2007) (37)
The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study (2012) (36)
Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX (2015) (36)
Development of a polygenic risk score to improve screening for fracture risk: A genetic risk prediction study (2020) (36)
In which patients does lumbar spine trabecular bone score (TBS) have the largest effect? (2018) (35)
High Serum SHBG Predicts Incident Vertebral Fractures in Elderly Men (2016) (35)
Low bone mineral density is associated with increased mortality in elderly men: MrOS Sweden (2011) (35)
Osteoporosis and fractures in women: the burden of disease (2021) (35)
Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective (2011) (33)
FRAX updates 2016 (2016) (33)
Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry (2018) (32)
Is the Swedish FRAX model appropriate for Swedish immigrants? (2015) (32)
Fracture Discrimination by Combined Bone Mineral Density (BMD) and Microarchitectural Texture Analysis (2015) (31)
FRAX® probabilities and risk of major osteoporotic fracture in France (2012) (31)
The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis (2010) (31)
SIGN Guidelines for Scotland: BMD Versus FRAX Versus QFracture (2016) (31)
The incidence of a first major osteoporotic fracture in Iceland and implications for FRAX (2014) (31)
Can Change in FRAX Score Be Used to “Treat to Target”? A Population‐Based Cohort Study (2014) (30)
The distribution of FRAX®-based probabilities in women from Japan (2012) (30)
FRAX provides robust fracture prediction regardless of socioeconomic status (2013) (29)
Low 25-OH vitamin D is associated with benign prostatic hyperplasia. (2013) (29)
Osteoporosis in Europe: a compendium of country-specific reports (2022) (28)
Extensive undertreatment of osteoporosis in older Swedish women (2019) (28)
Incidence of Hip Fracture in Barranquilla, Colombia, and the Development of a Colombian FRAX Model (2013) (28)
Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women (2013) (27)
Inflammatory bowel disease and the risk of fracture after controlling for FRAX (2013) (27)
How to decide who to treat. (2009) (26)
Evaluation of FRAX to characterise fracture risk in Poland (2011) (26)
Hip Fracture Incidence from 1981 to 2009 in the Czech Republic as a Basis of the Country-Specific FRAX Model (2012) (25)
Serum estradiol associates with blood hemoglobin in elderly men: the MrOS Sweden study. (2014) (25)
Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate (2017) (25)
Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance (2011) (24)
An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines (2021) (24)
Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures (2020) (23)
Potential Extensions of the US FRAX Algorithm (2012) (22)
Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model (2020) (21)
Waning predictive value of serum adiponectin for fracture risk in elderly men: MrOS Sweden (2014) (21)
Selection of women aged 50-64 yr for bone density measurement. (2013) (21)
Sarcopenia Definitions as Predictors of Fracture Risk Independent of FRAX®, Falls, and BMD in the Osteoporotic Fractures in Men (MrOS) Study: A Meta‐Analysis (2021) (20)
Fracture prediction from self-reported falls in routine clinical practice: a registry-based cohort study (2019) (19)
The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density (2020) (19)
FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry (2017) (18)
Evaluation of the FRAX Model for Hip Fracture Predictions in the Population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE) (2014) (18)
Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK—an analysis of anonymous website activity (2016) (18)
Response to Letter: "Cortical Bone Area Predicts Incident Fractures Independently of Areal Bone Mineral Density in Older Men". (2017) (18)
A comparative study of using non-hip bone density inputs with FRAX® (2012) (17)
Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models (2018) (17)
The effect on subsequent fracture risk of age, sex, and prior fracture site by recency of prior fracture (2021) (17)
The use of 2-, 5-, and 10-year probabilities to characterize fracture risk after a recent sentinel fracture (2020) (16)
High Plasma Erythropoietin Predicts Incident Fractures in Elderly Men with Normal Renal Function: The MrOS Sweden Cohort (2020) (15)
Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model (2020) (15)
Rationalisation du remboursement des médicaments de l'ostéoporose : de la mesure isolée de la densité osseuse à l'intégration des facteurs cliniques de risque fracturaire. Validation de l'algorithme FRAX(r) (2009) (14)
The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland. (2011) (13)
FRAX and ethnicity (2020) (13)
Use of age-dependent FRAX-based intervention thresholds for Singapore (2020) (13)
Development and application of FRAX in the management of osteoporosis in Ireland (2013) (13)
Clinically relevant doses of vitamin A decrease cortical bone mass in mice (2018) (13)
Appendicular lean mass and fracture risk assessment: implications for FRAX® and sarcopenia (2019) (13)
Loss in DXA-estimated total body lean mass but not fat mass predicts incident major osteoporotic fracture and hip fracture independently from FRAX: a registry-based cohort study (2020) (13)
High Serum Serotonin Predicts Increased Risk for Hip Fracture and Nonvertebral Osteoporotic Fractures: The MrOS Sweden Study (2018) (12)
Direct comparison of FRAXR and a simplified fracture risk assessment tool in routine clinical practice: a registry-based cohort study (2016) (12)
Measured height loss predicts incident clinical fractures independently from FRAX: a registry-based cohort study (2020) (11)
Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study (2020) (11)
Epidemiology of hip fracture in Botswana (2021) (11)
FRAX-based intervention and assessment thresholds for osteoporosis in Romania (2013) (11)
Epidemiology of Hip Fractures in Two Regions of Ukraine (2018) (11)
Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry (2018) (11)
FRAX-based intervention thresholds in eight Eurasian countries: Armenia, Belarus, Georgia, Kazakhstan, the Kyrgyz Republic, Moldova, the Russian Federation, and Uzbekistan (2021) (10)
Low risk for hip fracture and high risk for hip arthroplasty due to osteoarthritis among Swedish farmers (2018) (10)
Temporal changes in access to FRAX® in Thailand between 2010 and 2018 (2019) (10)
Fracture Risk in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry-Based Cohort Study. (2019) (9)
Adjustment of FRAX probability according to lumbar spine Trabecular Bone Score (TBS): The Manitoba BMD Cohort (2013) (9)
Epidemiology of hip fracture and the development of a FRAX model for Uzbekistan (2020) (9)
Predictive Value of DXA Appendicular Lean Mass for Incident Fractures, Falls, and Mortality, Independent of Prior Falls, FRAX, and BMD: Findings from the Women's Health Initiative (WHI) (2020) (9)
Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model (2019) (9)
Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study (2021) (9)
Fracture prediction from FRAX for Canadian ethnic groups: a registry-based cohort study (2020) (9)
Fracture risk assessment in celiac disease: a registry-based cohort study (2020) (9)
Low holotranscobalamin and cobalamins predict incident fractures in elderly men: the MrOS Sweden (2013) (8)
A Meta-Analysis Of Trabecular Bone Score In Fracture Risk Prediction And Its Interaction With Frax (2015) (7)
Pitfalls in the external validation of FRAX: response to Bolland et al. (2012) (7)
Total Hip Bone Area Affects Fracture Prediction With FRAX® in Canadian White Women (2017) (7)
Prior clinical vertebral fractures are a particularly strong predictor of hip fracture: A meta-analysis (2006) (7)
Ukrainian Version of FRAX: from Creation to Validation (2017) (7)
THE ECONOMIC BURDEN OF FRACTURES IN THE EUROPEAN UNION IN 2010 (2012) (7)
A surrogate FRAX model for the Kyrgyz Republic (2020) (7)
Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model (2020) (6)
FRAX-based fracture probabilities in South Africa (2021) (6)
Increased risk for hip fracture after death of a spouse—further support for bereavement frailty? (2019) (6)
Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM) (2021) (6)
Fracture Risk Assessment: The Development and Application of FRAX® (2013) (6)
FRAX-based intervention and assessment thresholds for osteoporosis in Iran (2019) (6)
High body mass index, adjusted for BMD, is a risk factor for fracture in women (2012) (5)
The Effect of Fracture Recency on Observed 10‐Year Fracture Probability: A Registry‐Based Cohort Study (2022) (5)
Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study (2020) (5)
High plasma osteocalcin is associated with low blood haemoglobin in elderly men: the MrOS Sweden Study (2016) (5)
Increased risk of hip fracture among spouses—evidence of a homogamy effect (2016) (5)
EPIDEMIOLOGY OF THE PROXIMAL FEMUR FRACTURES IN UKRAINE: RESULTS OF STOP-STUDY (SYSTEM OF REGISTRATION OF OSTEOPOROTIC FRACTURES IN UKRAINIAN POPULATION) (2016) (5)
Erratum to: A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX® (2011) (5)
Reassessment Intervals for Transition From Low to High Fracture Risk Among Adults Older Than 50 Years (2020) (4)
Analysis of Comorbidities, Clinical Outcomes, and Parathyroidectomy in Adults With Primary Hyperparathyroidism (2022) (4)
Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials (2022) (4)
Combining fracture outcomes in phase 3 trials of osteoporosis: an analysis of the effects of denosumab in postmenopausal women (2020) (3)
Expressing fracture risk (2008) (3)
Impact of population-based or targeted BMD interventions on fracture incidence (2021) (3)
Low holotranscobalamin and cobalamins predict incident fractures in elderly men; the MrOS Sweden (2012) (3)
Risk for hip fracture before and after total knee replacement in Sweden (2019) (3)
Incidence of hip fracture in Saudi Arabia and the development of a FRAX model (2022) (3)
Increased Risk of Hip Fracture in Patients with Lymphoma, a Swedish Population Study of 37,236 Lymphoma Patients (2020) (3)
Epidemiology of hip fracture in Qatar and development of a country specific FRAX model (2022) (3)
The application of FRAX in Saudi Arabia (2021) (3)
Correspondence in response to OSIN-D-18-00831 quantifying imminent risk (2019) (3)
A surrogate FRAX model for Pakistan (2021) (3)
Variations in latitude may or may not explain the worldwide variation in hip fracture incidence (2012) (3)
Bone Turnover Marker Profiling and Fracture Risk in Older Women: Fracture Risk from Age 75 to 90 (2022) (3)
[FRAX--model for 10-year fracture risk assessment. Support in the treatment of osteoporosis, according to preliminary Swedish guidelines]. (2011) (2)
Estimation of risk in the field of osteoporosis (2011) (2)
FRAX - A NEW TOOL FOR THE ASSESSMENT OF FRACTURE RISK: APPLICATION IN CLINICAL PRACTICE AND THRESHOLDS FOR INTERVENTION (2012) (2)
Incidence of myocardial infarction and associated mortality varies by latitude and season: findings from a Swedish Registry Study. (2019) (2)
THE PATTERN OF MORTALITY ASSOCIATED WITH BONE MINERAL DENSITY IN ELDERLY MEN - MROS SWEDEN (2010) (2)
Risk evaluation and treatment decisions (2012) (2)
Hip fracture prevalence in grandfathers is associated with reduced cortical cross-sectional bone area in their young adult grandsons. (2010) (2)
Diagnostic Thresholds for Osteoporosis in Men (2010) (2)
Greater pQCT Calf Muscle Density Is Associated with Lower Fracture Risk, Independent of FRAX, Falls and BMD: A Meta‐Analysis in the Osteoporotic Fractures in Men (MrOS) Study (2022) (1)
A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis: the impact of severe osteoporosis and contraindications (2014) (1)
Incidence of Hip Fracture in Romania and the Development of a Romanian FRAX Model (2013) (1)
European Congress on Osteoporosis & Osteoarthritis (ECCEO11-IOF) (2011) (1)
Screening for high fracture risk (2020) (1)
Highly increased risk of fracture in patients with myeloproliferative neoplasm (2020) (1)
Bazedoxifene reduces non-vertebral fractures in patients at high probability of fracture (2010) (1)
SIGN Guidelines for Scotland: BMD Versus FRAX Versus QFracture (2015) (1)
Spine-Hip Discordance and Fracture Risk Assessment: A Physician-Friendly FRAX Enhancement (2010) (1)
Correction to: Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures (2020) (1)
Epidemiology [301–314] 301. The Population Prevalence of Foot and Ankle Pain Over the Age of 45 Years: A Systematic Review (2010) (1)
Physical Performance Or Function, But Not Appendicular Lean Mass, Predict Incident Fractures Independently Of FRAX Probability And BMD : Results From The Osteoporotic Fractures In Men (MROS) Cohort (2018) (1)
Ukrainian frax: criteria for diagnostics and treatment of osteoporosis (2019) (1)
High serum adiponectin predicts incident fractures in elderly men : mr os sweden (2011) (1)
A country-specific FRAX model for Botswana (2021) (1)
FRAX-Based Intervention Thresholds for Osteoporosis Treatment in Ukraine (2021) (1)
Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK (2008) (1)
A Meta-Analysis of Reference Markers of Bone Turnover for Prediction of Fracture (2014) (1)
Trabecular Bone Score Adjustment for the Fracture Risk Assessment Tool (FRAX®) (2022) (1)
Inappropriate Use of Cost-effectiveness Thresholds as Intervention Thresholds - Potential for Overtreatment of Low Risk Individuals (2018) (1)
Waning Long-Term Predictive Value Of Falls History For Incident Fracture : MROS Sweden (2015) (1)
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2014): Oral Communication Abstracts (2014) (0)
Frax Predicts Incident Falls in Elderly Women: Findings From Australia (2015) (0)
Osteoporosis treatment in Austria—assessment of FRAX-based intervention thresholds for high and very high fracture risk (2022) (0)
The Performance of FRAX (R) According to Different Levels of Socioeconomic Status (2013) (0)
The application of FRAX in Ecuador (2021) (0)
Effect of Discordant Hip Bone Density on Incident Fracture Risk: A Registry‐Based Cohort Study (2022) (0)
Increased Risk of Hip Fracture in Patients with Lymphoma, a Swedish Population Study of 37,236 Lymphoma Patients (2020) (0)
PB1802 INCREASED RISK OF HIP FRACTURES IN YOUNG WOMEN WITH LYMPHOMA, RESULTS FROM A SWEDISH POPULATION BASED STUDY (2019) (0)
Mobility Related Risk Factors Predict Incident Fractures Independently Of Frax : The Osteoporotic Fractures In Men (MROS) Study (2017) (0)
Cost-Effectiveness of Abaloparatide for the Treatment of Postmenopausal Women with Osteoporosis (2018) (0)
Recent sarcopenia definitions—prevalence, agreement and mortality associations among men: Findings from population‐based cohorts (2023) (0)
A MISSED OPPORTUNITY: WHAT PROPORTION OF FRACTURE PATIENTS HAVE HAD A PRIOR FRACTURE? (2018) (0)
PMS20 A COMPARISON OF DIFFERENT METHODS OF ESTIMATING FRACTURE RISK AND FRACTURE RISK REDUCTION IN COST-EFFECTIVENESS ANALYSES OF THE OSTEOPOROSIS TREATMENT BAZEDOXIFENE (2009) (0)
Elderly men with diabetes sustain hip fractures at higher BMD. Mr Os Sweden (2011) (0)
European Congress on Osteoporosis & Osteoarthritis (IOF-ECCEO12) (2012) (0)
Genomic Prediction of Osteoporosis Using 426,000 Individuals from UK Biobank (2018) (0)
Clinical Characteristics and Outcomes in Patients with Hospital-Based Diagnosis of Primary Hyperparathyroidism – a National Retrospective Cohort Study (2021) (0)
Potential Adverse Effect of Nonsteroidal Anti‐Inflammatory Drugs (NSAIDs) on Bisphosphonate Efficacy: An Exploratory Post Hoc Analysis From a Randomized Controlled Trial of Clodronate (2022) (0)
High Serum Cystatin C Predicts Incident Hip Fracture in Elderly Men : MROS Sweden (2012) (0)
General Comorbidity Indicators Contribute to Fracture Risk Independent of FRAX: Registry-Based Cohort Study. (2022) (0)
Fracture Discrimination by Combined Bone Mineral Density (BMD) and Microarchitectural Texture Analysis (2015) (0)
Application of WHO fracture prediction algorithm to estimate the 10-year osteoporotic fracture probability in Hong Kong southern Chinese (2008) (0)
Primary hyperparathyroidism and fracture probability (2022) (0)
Does vitamin D status impact on hip fracture incidence?: evidence of fracture variation with latitude and season in Sweden (2013) (0)
Performance of FRAX in Men with Prostate Cancer: A Registry-Based Cohort Study. (2023) (0)
(2020). Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study. Osteoporosis (2020) (0)
Adjusting conventional FRAX estimates of fracture probability according to the number of prior fractures (2022) (0)
Epidemiology Of Hip Fractures In Ukraine: Results Of STOP-Study (2018) (0)
THE PREDICTIVE VALUE OF PAST FALLS FOR INCIDENT FALLS DECREASES, BUT THAT OF FRAX REMAINS STABLE, WITH INCREASING FOLLOW-UP TIME: FINDINGS FROM MROS SWEDEN (2015) (0)
PRIOR FALLS PREDICT INCIDENT FRACTURES INDEPENDENTLY OF FRAX : The Osteoporotic Fractures In Men (MROS) Study (2017) (0)
FREM predicts 10-year incident fracture risk independent of FRAX® probability: a registry-based cohort study (2022) (0)
Estimates of fracture probability in Denmark (2007) (0)
FRAX[trade] and the assessment of fracture probability: An introduction (2008) (0)
Measures of physical performance or function, but not appendicular lean mass, predict new fractures independently of FRAX probability : Findings from MrOS (2017) (0)
Non-vertebral fracture risk reduction by bazedoxifene (2010) (0)
Revêtements de surface homogènes décoratifs sans halogène (2016) (0)
Fracture Discrimination Is Improved by Combining BMD and Micro-Architectural Texture Analysis Assessed by H or TBS (2014) (0)
Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year (2022) (0)
Le démarreur progressif PST adoucit les mo(t)eurs : PST : polyglotte de naissance (2004) (0)
[A FRAX model for the assessment of fracture probability in Belgium]. (2009) (0)
Femoral Neck BMD Is Still The Preferred Site In The Assessment Of Hip Fracture In Elderly Men (10-Year Follow-Up Of MROS Sweden) (2016) (0)
Estimates of fracture probability in Denmark. Author's reply (2007) (0)
Impact of Femoral Neck and Lumbar Spine BMD Discordances on FRAX Probabilities in Women: A Meta-analysis of International Cohorts (2014) (0)
FRAX I OTsENKA RISKA PERELOMA U MUZhChIN I ZhENShchIN V VELIKOBRITANII (2008) (0)
FRAX(r) and the assessment of fracture probability in men and women from Belgium. (2009) (0)
Adiponectin and 10-year probability of fracture in elderly men : MR OS Sweden (2013) (0)
FRAX® with and without Bone Mineral Density (2011) (0)
FRAX-based intervention thresholds for Pakistan (2021) (0)
PROOF COVER SHEET (2015) (0)
Impact oVarying BMD Resources on Prediction of Hip Fracture Using Frax (2009) (0)
Application of FRAX to determine the risk of osteoporotic fractures in the Ukrainian population (2018) (0)
Evaluation of the FRAX Model for Hip Fracture Predictions in the Population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE) (2014) (0)
A Helping of Hip and a Sprinkling of Spine: The Blended T-score is Equivalent to the Offset Enhancement for Fracture Prediction with FRAX (2011) (0)
Adjusting Fracture Probability by Trabecular Bone Score (2015) (0)
Hip Fracture Incidence from 1981 to 2009 in the Czech Republic as a Basis of the Country-Specific FRAX Model (2012) (0)
Procédé et dispositif pour déterminer au moins un paramètre lors du passage d'une bande de matière à travers une fente formée entre deux surfaces capables de tourner et utilisation (2008) (0)
DANGER OF OVERTREATMENT OF OSTEOPOROSIS WITH INAPPROPRIATE USE OF INTERVENTION THRESHOLDS DERIVED BY COST-EFFECTIVENESS ANALYSIS (2018) (0)
Adjustment of FRAX for women according to BMD at the lumbar spine (2012) (0)
Assessing the Impact of Osteoporosis on the Burden of Hip Fractures (2012) (0)
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Special Lecture Abstract (2020) (0)
FRAX Adjustment by Trabecular Bone Score with or Without Bone Mineral Density: The Manitoba BMD Registry. (2023) (0)
An assessment of intervention thresholds for high fracture risk in Chile. (2022) (0)
IOF Regionals – 6th Asia-Pacific Osteoporosis Meeting (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Helena Johansson?

Helena Johansson is affiliated with the following schools: